Optical Coherence Tomography (OCT) Findings in Post-COVID-19 Healthcare Workers
- PMID: 40558794
- PMCID: PMC12193844
- DOI: 10.3390/jimaging11060195
Optical Coherence Tomography (OCT) Findings in Post-COVID-19 Healthcare Workers
Abstract
Recent evidence suggests that SARS-CoV-2 may induce subtle anatomical changes in the retina, detectable through advanced imaging techniques. This retrospective case-control study utilized optical coherence tomography (OCT) to assess medium-term retinal alterations in 55 healthcare workers, including 25 individuals with PCR-confirmed COVID-19 and 30 non-COVID-19 controls, all of whom had worked in COVID-19 clinical settings. Comprehensive ophthalmological examinations, including OCT imaging, were conducted six months after infection. The analysis considered demographic variables, comorbidities, COVID-19 severity, risk factors, and treatments received. Central macular thickness (CMT) was significantly increased in the post-COVID-19 group (p < 0.05), with a weak but statistically significant positive correlation between CMT and disease severity (r = 0.245, p < 0.05), suggesting potential post-inflammatory retinal responses. No significant differences were observed in retinal nerve fiber layer (RNFL) or ganglion cell complex (GCL + IPL) thickness. However, mild negative trends in inferior RNFL and average GCL+IPL thickness may indicate early neurodegenerative changes. Notably, patients with comorbidities exhibited a significant reduction in superior and inferior RNFL thickness, pointing to possible long-term neurovascular impairment. These findings underscore the value of OCT imaging in identifying subclinical retinal alterations following COVID-19 and highlight the need for continued surveillance in recovered patients, particularly those with pre-existing systemic conditions.
Keywords: neurovascular imaging; optical coherence tomography; post-COVID-19 retinal changes.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Chung M.K., Karnik S., Saef J., Bergmann C., Barnard J., Lederman M.M., Tilton J., Cheng F., Harding C.V., Young J.B., et al. SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. EBioMedicine. 2020;58:102907. doi: 10.1016/j.ebiom.2020.102907. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
